UNSPSC 51385202: Proquazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C18H18N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 42VPJ2980S, chemically known as 2(1h)-quinazolinone, 7-methyl-1-(1-methylethyl)-4-phenyl- but generally known as proquazone, which bears US NIH Compound Identifier 31508. European Medicines Agency schedules Proquazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10127MIG.

UNSPSC 51385202 Proquazone is a Commodity code that covers pharmaceutical products and related medical supplies procured by state and local health agencies, though the recent opportunity tagged under this code actually involves naloxone (an opioid antagonist medication) and drug deactivation systems rather than proquazone specifically. State and local procurement under this code span public health departments, county health systems, and community health agencies that purchase medications and medical devices to support public health initiatives, emergency response, and substance-abuse intervention programs. The scope includes the supply of finished pharmaceutical units, delivery logistics, and compliance with drug-free workplace and employment verification requirements. Issuing bodies are typically county or municipal health departments and special-purpose health districts managing community health services.

Seminole County, Florida represents the primary recent activity visible under this code. The county's IFB 60459723LAS, posted June 30, 2026, solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under a two-year contract with one-year renewal option; the response deadline was July 26, 2023, at 2:00 pm, and vendors were required to submit bids electronically with all shipping and delivery costs included in pricing. The procurement included standard compliance requirements (drug-free workplace certification, E-Verify) and maintained a three-month probationary termination clause. Beyond this single recent opportunity, the source supports no additional state or local activity under this code.